a good marker ofWilson's disease, might also be useful for monitoring fetal development in high-risk
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390 CLINICAL CHEMISTRY, Vol. 36, No. 2 , 1990 Measurement of 1,25(OH)2D3 in serum has been laborious and time consuming. In most assays a preparative chromatography procedure is used, followed by HPLC, before radioreceptor assay. Hollis (3) reported a method requiring a single preparative chromatographic procedure (C180H columns). We measured 1,25(OH)2D3 in serum from normal adults and adult patients with functioning kidney grafts, using a commercial kit (Nichols Institute, cat. no. 40-2201) based on this procedure. The manufacturer's instructions were rigorously followed.
Subjects studied were as follows: Group 1) 20 healthy volunteers (10 men, 10 women) without renal, skeletal, or hepatic diseases and with a normal biochemical profile. Concentrations of laminin, a main constituent of basement membranes, in serum are significantly increased in various diseases: chronic active liver disease (1), rheumatoid arthritis (2), hyperthyroidism (3), diabetes (4), and tumors (5). We now report increased concentrations of laminin in sera ofpatients with monoclonal gammopathies.
Laminin was determined in serum by a radioimmunoassay, kindly provided by Dr. Strecker (Hoechst AGlBehringwerke AG, Frankfurt, F.R.G.), the analytical Criteria of which have been reported (1). Monoclonal gammopathies were identified by immunofixation electrophoresis. Immunoglobulins G, A, and M were measured and immunoglobulin light-chain composition was determined by using automated fixed-time immunonephelometry (Behring Nephelometer System; Behringwerke AG, Marburg, F.R.G.). For statistical evaluation, we used the Mann-Whitney test for comparison of means and the Spearman rank correlation coefficient. From the patients with monoclonal gammopathies, those with serum creatinine concentrations above the upper reference limit (106 pmolfL) were excluded, because patients with renal insufficiency may show increased concentrations of laminin in serum (4). The remaining 54 patients with monoclonal gammopathies showed significantly increased concentrations (1.51 ± 0.42 kU/L,P <0.001) oflaniinin in serum as compared with a reference population ofhealthy blood donors (1.06 ± 0.15 kU/L, n = 146). This was most pronounced for IgG gammopathies (n = 30, 19 ofthem type kappa) followed by IgA garnmopathies (n = 16, nine type kappa), whereas the increase for 1gM gammopathies (n = 8, seven type kappa) was not statistically significant (Figure 1) . Assuming Caffeine concentrations in serum and saliva correlate well (1). Various analytical approaches have been described for measuring caffeine and paraxanthine in serum, but no rapid, accurate, and inexpensive method, adaptable to automation, has yet been reported for saliva. The following cost-effective, quantitative micro-scale assay was developed for a study examining the association between caffeine and symptomatology, involving several thousand saliva samples.
Vortex-mix patients' saliva or caffeine/paraxanthinesupplemented saliva and filter the suspension through a sintered-glass funnel (Pyrex Size 0, 161-to 250-pm pore size). Vortex-mix 100 L ofthe filtrate with an equal volume of methanol containing 7-(2-hydroxyethyl)theophylline, Under the above conditions, the retention time for paraxanthine is 3.5 mm, for the internal standard 4.1 miii, and for caffeine 5.6 mm. Use peak-height ratios to prepare the standard curve and calculate concentrations. After each day's run of approximately 100 assays, wash the column with methanol/dimethyl sulfoxide (90/10, by vol), then store it overnight in methanol.
The detection limit, defined as twice the height of the noise level, is 0.5 tmol/L for both analytes. Concentration and peak height are linearly related throughout the concentration range measured, 0.5-150 pmolJL. For concentrations of 5 pmol/L in saliva, the within-day and dayto-day CVs were 2.9% and 4.1% for caffeine and 3.7% and 4.2% for paraxanthine, respectively. Analytical recovery of caffeine and paraxanthine added to saliva to give concentrations of 1, 10, and 50 pmol/L was calculated by comparison with methanol solutions of caffeine, paraxanthine, and internal standard of equivalent concentrations; absolute recoveries ranged from 95% to 102%. Other xanthine dorivatives, including theophylline, did not interfere.
Filtration was used in preference to centrifugation because, in the initial work-up of the method, I found that concentrations of caffeine and paraxanthine were diminished when saliva was centrifuged, presumably through their binding to co-precipitated protein. Jrtjection of untreated saliva, on the other hand, caused column blockages, making it unsatisfactory for automation. I precipitated protein with methanol, because denaturation with acetonitrile or trichioroacetic acid produced considerably distorted and broad xanthine peaks.
